Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
06/2010
06/10/2010US20100144757 Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics
06/10/2010US20100144751 IMIDAZO[1,2-a]PYRIDINE COMPOUNDS AS RECEPTOR TYROSINE KINASE INHIBITORS
06/10/2010US20100144745 Pyrrolopyrazinyl Urea Kinase Inhibitors
06/10/2010US20100144743 Compositions and methods for inhibition of tyrosine kinases
06/10/2010US20100144730 Pyridinonyl pdk1 inhibitors
06/10/2010US20100144705 Egfr kinase knockdown via electrophilically enhanced inhibitors
06/10/2010US20100144700 Heterocyclic-carbonyl-diazabicycloalkanes as modulators of the neuronal nicotinic acetylcholine alpha 4 beta 2, subtype receptor for the treatment of cns related disorders
06/10/2010US20100144693 Method of treatment of age-related macular degeneration (amd)
06/10/2010US20100144043 Molecular fluorescence sensor for highly sensitive and selective detection of mercury
06/10/2010US20100143474 B-carboline for the treatment of neurodegenerative diseases
06/10/2010US20100143384 NOVEL 4-CYANO, 4-AMINO, AND 4-AMINOMETHYL DERIVATIVES OF PYRAZOLO[1,5-a]PYRIDINES, PYRAZOLO[1,5-c]PYRIMIDINES AND 2H-INDAZOLE COMPOUNDS AND 5-CYANO, 5-AMINO, AND 5-AMINOMETHYL DERIVATIVES OF IMIDAZO[1,2-a]PYRIDINES, AND IMIDAZO[1,5-a]PYRAZINES AS CYCLIN DEPENDENT KINASE INHIBITORS
06/10/2010US20100143253 Compounds and amyloid probes thereof for therapeutic and imaging uses
06/10/2010US20100141122 Oled device with cyclobutene electron injection materials
06/10/2010DE102008059578A1 Benzo-Naphtyridin Verbindungen Benzo-naphtyridine connections
06/10/2010CA2745721A1 Substituted piperidine spiro pyrrolidinone and piperidinones used as h3 modulators
06/10/2010CA2745690A1 Novel polymorphic forms of an azabicyclo-trifluoromethyl benzamide derivative
06/10/2010CA2745041A1 2, 5-diamino-substituted pyrido [4, 3-d] pyrimidines as autotaxin inhibitors against cancer
06/10/2010CA2745019A1 Quinolone compound and pharmaceutical composition
06/10/2010CA2744647A1 Imidazopyridine derivatives which inhibit the secretion of gastric acid
06/10/2010CA2744128A1 Spiroheterocyclic n-oxyamides as pesticides
06/09/2010EP2194057A1 Stable crystalline salts of 5-methyltetrahydrofolic acid
06/09/2010EP2194056A1 Novel 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivatives and their medical use
06/09/2010EP2194055A1 Bridged pyridoquinazoline or phenanthroline compounds and organic semiconducting material comprising that compound
06/09/2010EP2194043A2 Processes and intermediates
06/09/2010EP2193130A1 Pyrazolo-pyridines as tyrosine kinase inhibitors
06/09/2010EP2193121A1 Quinolin-4-one and 4-oxodihydrocinnoline derivatives as inhibitors of poly(adp-ribose)polymerase (parp)
06/09/2010EP2193118A2 Piperidine and piperazine derivatives for treating tumours
06/09/2010EP1740584B9 Fused quinoline derivative and use thereof
06/09/2010CN1982309B Industrial synthesis method for producing tropenol
06/09/2010CN1953985B Prodrugs of piperazine and substituted piperidine antiviral agents
06/09/2010CN1894247B Bispidon-derived ligands and complex for catalytically bleaching a substrate
06/09/2010CN1882589B Novel heterocyclic compounds as HSP90-inhibitors
06/09/2010CN1880319B Tropane derivatives as CCR5 modulators
06/09/2010CN1784391B Quinazolines useful as modulators of ion channels
06/09/2010CN1780835B Novel fused heterocycles and uses thereof
06/09/2010CN101730696A 3-aza-bicyclo[3.3.0]octane compounds
06/09/2010CN101724002A Double salt formed by inosine and matrine or oxymatrine and application thereof in field of medicaments
06/09/2010CN101723990A Complex salt consisting of glucuronic acid or glucurolactone and kushenin or matrine and application thereof
06/09/2010CN101723949A Polycyclic agents for the treatment of respiratory syncytial virus infections
06/09/2010CN101723944A Compound formed from ferulic acid and matrine compound and purpose thereof
06/09/2010CN101723941A '1,2,4' oxadiazoles as modulators of metabotropic glutamate receptor-5
06/09/2010CN101723936A Kinase suppressor and pharmaceutical application thereof
06/09/2010CN101723893A 2,3-disubstituted-2,3-dihydro quinoline ketone chiral compound as well as preparation method and application thereof
06/09/2010CN101056877B Imidazoquinoline compounds
06/08/2010US7732610 Heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents
06/08/2010US7732609 5-(arylsulfonyl)-pyrazolopiperidines
06/08/2010US7732607 Heteroaryl-substituted diazatricycloalkanes and methods of use thereof
06/08/2010US7732604 Triazolopyrazine derivatives
06/08/2010US7732603 Organic compounds as agents for the treatment of aldosterone mediated conditions
06/08/2010US7732461 Tryclic nitrogen containing compounds and their use as antibacterials
06/08/2010US7732460 Heterocyclic compounds, their preparation and their use as antibacterials
06/08/2010US7732456 such as 4-benzyloxy-1-{4-[2-(dimethylamino)ethoxy]phenyl}-1H-pyridin-2-one, that as antagonists to melanin concentrating hormone receptors, used for treating cardiovascular, nervous system, metabolic, reproductive system, respiratory system and gatrointestinal disorders
06/08/2010US7732437 Such as 3-[2-[4-(11,12-dihydro-6H-benzimidazo[2,1-b][3]benzazepin-6-yl)-2-(phenyl-methyl)-1-piperidinyl]ethyl]-2,10-dimethyl pyrimido[1,2- alpha ]benzimidazol-4(10H)-one
06/08/2010US7731985 Preserving cosmetic, household or technical products, use in paper treatment liquors, printing thickeners, printing thickeners of starch or cellulose derivatives and paints
06/03/2010WO2010062559A1 Substituted pyrazoloquinolines and derivatives thereof
06/03/2010WO2010062159A1 Bioactive compounds
06/03/2010WO2010062107A1 Organic electroluminscent device using electroluminescent compounds
06/03/2010WO2010060854A1 Bicyclic pyrazole and isoxazole derivatives as antitumor and antineurodegenerative agents
06/03/2010WO2010060589A1 Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors
06/03/2010WO2010060532A1 Benzonaphtyridine compounds used as inhibitors of autotaxin
06/03/2010WO2010060228A1 Enantioselective synthesis of asymmetric beta-carboline intermediates
06/03/2010WO2010027424A3 9-substituted phenanthrene based tylophorine derivatives
06/03/2010WO2009154300A3 Heterocyclic compound and use thereof
06/03/2010US20100137600 Photogenerated reagents
06/03/2010US20100137585 Fused heteroaryl derivatives
06/03/2010US20100137584 Fused heteroaryl derivatives
06/03/2010US20100137356 Azaindole-indole coupled derivatives, preparation methods and uses thereof
06/03/2010US20100137355 Nitrogenous heterocyclic compounds, preparation thereof and use thereof as antibacterial medicaments
06/03/2010US20100137353 Tricyclic compounds as antibacterials
06/03/2010US20100137351 Imidazoacridinone derivative compounds and methods for their use
06/03/2010US20100137349 Antimicrobial oxazolidinone, hydantoin and imidazolidinone compositions
06/03/2010US20100137326 NOVEL 4-CYANO, 4-AMINO, AND 4-AMINOMETHYL DERIVATIVES OF PYRAZOLO[1,5-a]PYRIDINES, PYRAZOLO[1,5-c]PYRIMIDINES AND 2H-INDAZOLE COMPOUNDS AND 5-CYANO, 5-AMINO, AND 5-AMINOMETHYL DERIVATIVES OF IMIDAZO[1,2-a]PYRIDINES, AND IMIDAZO[1,5-a]PYRAZINES AS CYCLIN DEPENDENT KINASE INHIBITORS
06/03/2010US20100137317 1,2-Disubstituted Heterocyclic Compounds
06/03/2010US20100137310 Renin inhibitors
06/03/2010US20100137306 Heterocyclic trpv1 receptor ligands
06/03/2010US20100137297 Spiroindalones
06/03/2010US20100137290 Oxazolidinone antibiotic derivatives
06/03/2010US20100137288 Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof
06/03/2010US20100137283 Inhibitors of the hiv integrase enzyme
06/03/2010US20100137280 Azetidin compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
06/03/2010US20100137279 4-methylpyridopyrimidinone compounds
06/03/2010US20100137276 Compounds which potentiate ampa receptor and uses thereof in medicine
06/03/2010US20100137270 Modulation of prostaglandin/cyclooxygenase metabolic pathways
06/03/2010US20100137230 New pyridin-2-one compounds
06/03/2010US20100137215 Novel tetrahydro-1h-pyrido[4,3-b]indoles
06/03/2010US20100136142 Substituted-4-aryl-1,4-dihydro-1,6-naphthyridinamides and use thereof
06/03/2010US20100135906 In vivo imaging of sulfotransferases
06/03/2010US20100133519 Arylamine compounds and electronic devices
06/03/2010CA2744833A1 Benzonaphtyridine compounds as inhibitors of autotaxin
06/03/2010CA2744138A1 Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors
06/03/2010CA2741303A1 Substituted pyrazoloquinolines and derivatives thereof
06/02/2010EP2192120A1 Stable crystalline salt of 5-methyll-(6S)-tetrahydrofolic acid
06/02/2010EP2192116A1 Indazole acrylic acid amide compound
06/02/2010EP2190848A1 Novel 1,4-diaza-bicyclo[3.2.2]nonyl heteroaryl derivatives useful as nicotinic acetylcholine receptor ligands
06/02/2010EP2190847A1 Novel 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivatives useful as nicotinic acetylcholine receptor ligands
06/02/2010EP2190846A1 1,4-diaza-bicycl0(3.2.2)n0nyl pyrimidinyl derivatives useful as nicotinic acetylcholine- receptor ligands
06/02/2010EP2190845A2 Hdac inhibitors
06/02/2010EP2190824A1 Naphthylpyrimidine, naphthylpyrazine and naphthylpyridazine analogs and their use as agonists of the wnt-beta-catenin cellular messaging system
06/02/2010EP2102207B1 Spiro-piperidine derivatives as via receptor antagonists
06/02/2010EP2099799B1 Spiro-piperidine derivatives
1 ... 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 ... 646